Literature DB >> 11274598

In vitro and in vivo measurements of human RBCs frozen with glycerol and subjected to various storage temperatures before deglycerolization and storage at 4 degrees C for 3 days.

C R Valeri1, L E Pivacek, G P Cassidy, G Ragno.   

Abstract

BACKGROUND: This study was designed to assess the effects of changes in storage temperature of frozen RBCs such as might occur during a malfunction of the -80 degrees C mechanical freezer or during shipment. STUDY DESIGN AND METHODS: Fifteen participants donated blood for autologous transfusion of RBCs; all RBCs were frozen with 40-percent (wt/vol) glycerol. Five subjects received RBCs that were stored at -80 degrees C alone before transfusion. Five subjects received RBCs that were stored initially at -80 degrees C, then at -40 degrees C for 4 weeks, and finally at -80 degrees C before transfusion. Five subjects received RBCs that were stored at -80 degrees C, then at -20 degrees C for 2 weeks, and finally at -80 degrees C before transfusion. After deglycerolization, the RBCs were stored at 4 degrees C in a sodium chloride-glucose solution for 3 days before transfusion.
RESULTS: No significant differences were observed in freeze-thaw recovery, freeze-thaw-wash recovery, 24-hour posttransfusion survival, index of therapeutic effectiveness, or RBC ATP levels. Greater hemolysis and reduced RBC K+ levels were observed in the units stored at -80 degrees C/-40 degrees C/-80 degrees C and in those stored at -80 degrees C/ -20 degrees C/-80 degrees C compared with the units stored at -80 degrees C alone, but these differences did not affect the 24-hour posttransfusion survival.
CONCLUSIONS: The results of this study indicated that RBCs frozen with 40-percent (wt/vol) glycerol can be stored at -40 degrees C for 4 weeks or at -20 degrees C for 2 weeks between periods of frozen storage at -80 degrees C with satisfactory results.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274598     DOI: 10.1046/j.1537-2995.2001.41030401.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

2.  Emerging Role for Use of Liposomes in the Biopreservation of Red Blood Cells.

Authors:  Jelena L Holovati; Jason P Acker
Journal:  Transfus Med Hemother       Date:  2011-03-21       Impact factor: 3.747

3.  From Development to Implementation: Adjusting the Hematocrit of Deglycerolized Red Cell Concentrates to Meet Regulatory Standards.

Authors:  Tracey Turner; Adele Hansen; Jayme Kurach; Jason P Acker
Journal:  Transfus Med Hemother       Date:  2016-11-04       Impact factor: 3.747

4.  Continuous removal of glycerol from frozen-thawed red blood cells in a microfluidic membrane device.

Authors:  Ratih E Lusianti; Adam Z Higgins
Journal:  Biomicrofluidics       Date:  2014-10-28       Impact factor: 2.800

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.